Cesari M, Vellas B, Gambassi G. The stress of aging. Exp Gerontol. 2013;48:451–6. https://doi.org/10.1016/j.exger.2012.10.004.
Sieber CC. Frailty – from concept to clinical practice. Exp Gerontol. 2017;87:160–7. https://doi.org/10.1016/j.exger.2016.05.004.
Chang S-F, Lin P-L. Frail phenotype and mortality prediction: a systematic review and meta-analysis of prospective cohort studies. Int J Nurs Stud. 2015;52:1362–74. https://doi.org/10.1016/j.ijnurstu.2015.04.005.
Nascimento CM, Ingles M, Salvador-Pascual A, Cominetti MR, Gomez-Cabrera MC, Viña J. Sarcopenia, frailty and their prevention by exercise. Free Radic Biol Med. 2019;132:42–9. https://doi.org/10.1016/j.freeradbiomed.2018.08.035.
Article CAS PubMed Google Scholar
Hardy SE, Perera S, Roumani YF, Chandler JM, Studenski SA. Improvement in usual gait speed predicts better survival in older adults. J Am Geriatr Soc. 2007;55:1727–34. https://doi.org/10.1111/j.1532-5415.2007.01413.x.
Himann JE, Cunningham DA, Rechnitzer PA, Paterson DH. Age-related changes in speed of walking. Med Sci Sports Exerc. 1988;20:161–6. https://doi.org/10.1249/00005768-198820020-00010.
Article CAS PubMed Google Scholar
Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. JAMA. 2011;305:50–8. https://doi.org/10.1001/jama.2010.1923.
Article CAS PubMed PubMed Central Google Scholar
de Vries AW, Faber G, Jonkers I, Van Dieen JH, Verschueren SMP. Virtual reality balance training for elderly: similar skiing games elicit different challenges in balance training. Gait Posture. 2018;59:111–6. https://doi.org/10.1016/j.gaitpost.2017.10.006.
de Vries NM, van Ravensberg CD, Hobbelen JSM, Olde Rikkert MGM, Staal JB, Nijhuis-van der Sanden MWG. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and/or multi-morbidity: a meta-analysis. Ageing Res Rev. 2012;11:136–149. https://doi.org/10.1016/j.arr.2011.11.002
Liu-Ambrose T, Khan KM, Eng JJ, Janssen PA, Lord SR, Mckay HA. Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial. J Am Geriatr Soc. 2004;52:657–65. https://doi.org/10.1111/j.1532-5415.2004.52200.x.
Article PubMed PubMed Central Google Scholar
Peluso A, Damgaard MV, Mori MAS, Treebak JT. Age-dependent decline of nad(+)-universal truth or confounded consensus? Nutrients. 2021;14:101. https://doi.org/10.3390/nu14010101.
Article CAS PubMed PubMed Central Google Scholar
She J, Sheng R, Qin ZH. Pharmacology and potential implications of nicotinamide adenine dinucleotide precursors. Aging Dis. 2021;12:1879–97. https://doi.org/10.14336/ad.2021.0523.
Article PubMed PubMed Central Google Scholar
Chu X, Raju RP. Regulation of nad(+) metabolism in aging and disease. Metabolism. 2022;126:154923. https://doi.org/10.1016/j.metabol.2021.154923.
Article CAS PubMed Google Scholar
Fang EF, Lautrup S, Hou Y, Demarest TG, Croteau DL, Mattson MP, et al. Nad(+) in aging: molecular mechanisms and translational implications. Trends Mol Med. 2017;23:899–916. https://doi.org/10.1016/j.molmed.2017.08.001.
Article CAS PubMed PubMed Central Google Scholar
Radenkovic D, Reason, Verdin E. Clinical evidence for targeting NAD therapeutically. Pharmaceuticals (Basel). 2020;13:247. https://doi.org/10.3390/ph13090247
Zhang M, Ying W. Nad(+) deficiency is a common central pathological factor of a number of diseases and aging: mechanisms and therapeutic implications. Antioxid Redox Signal. 2019;30:890–905. https://doi.org/10.1089/ars.2017.7445.
Article CAS PubMed Google Scholar
Yoshino J, Baur JA, Imai SI. Nad(+) intermediates: the biology and therapeutic potential of nmn and nr. Cell Metab. 2018;27:513–28. https://doi.org/10.1016/j.cmet.2017.11.002.
Article CAS PubMed Google Scholar
Campagna R, Vignini A. Nad(+) homeostasis and nad(+)-consuming enzymes: Implications for vascular health. Antioxidants (Basel). 2023;12:376. https://doi.org/10.3390/antiox12020376.
Article CAS PubMed Google Scholar
Kim M, Seol J, Sato T, Fukamizu Y, Sakurai T, Okura T. Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: a randomized, double-blind placebo-controlled study. Nutrients. 2022;14:755. https://doi.org/10.3390/nu14040755.
Article CAS PubMed PubMed Central Google Scholar
Wolkove N, Elkholy O, Baltzan M, Palayew M. Sleep and aging: 1. Sleep disorders commonly found in older people. Canadian Med Assoc J. 2007;176:1299–304. https://doi.org/10.1503/cmaj.060792.
Prinz PN, Vitiello MV, Raskind MA, Thorpy MJ. Sleep disorders and aging. N Eng J Med. 1990;323:520–6. https://doi.org/10.1056/NEJM199008233230805.
Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. Npj Aging. 2022;8:5. https://doi.org/10.1038/s41514-022-00084-z.
Article CAS PubMed PubMed Central Google Scholar
Oba K, Ishikawa J, Tamura Y, Fujita Y, Ito M, Iizuka A, et al. Serum growth differentiation factor 15 level is associated with muscle strength and lower extremity function in older patients with cardiometabolic disease. Geriatr Gerontol Int. 2020;20:980–7. https://doi.org/10.1111/ggi.14021.
de Fátima Ribeiro Silva C, Ohara DG, Matos AP, Pinto ACPN, Pegorari MS. Short physical performance battery as a measure of physical performance and mortality predictor in older adults: a comprehensive literature review. Int J Environ Res Public Health. 2021;18:10612. https://doi.org/10.3390/ijerph182010612
Konuma H, Hirose H, Yokoyama K. Relationship of the japanese translation of the profile of mood states second edition (POMS 2®) to the First Edition (POMS®). Juntendo Med J. 2015; 61: 517–519.https://doi.org/10.14789/jmj.61.517
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. https://doi.org/10.1016/0165-1781(89)90047-4.
Article CAS PubMed Google Scholar
Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. The efficacy and safety of β-nicotinamide mononucleotide (nmn) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45:29–43. https://doi.org/10.1007/s11357-022-00705-1.
Article CAS PubMed Google Scholar
Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372:1224–9. https://doi.org/10.1126/science.abe9985.
Article CAS PubMed PubMed Central Google Scholar
Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, et al. Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Front Nutr. 2022;9:868640. https://doi.org/10.3389/fnut.2022.868640.
Article CAS PubMed PubMed Central Google Scholar
Trammell SAJ, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. https://doi.org/10.1038/ncomms12948.
Article CAS PubMed PubMed Central Google Scholar
Martens CR, Denman BA, Mazzo MR, A
留言 (0)